BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Watanabe K. Clinical management for small bowel of Crohn's disease in the treat-to-target era: now is the time to optimize treatment based on the dominant lesion. Intest Res. 2020;18:347-354. [PMID: 33131231 DOI: 10.5217/ir.2020.00032] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Yang C, Yen H, Chen Y, Su P, Huang S. Radiation Exposure among Patients with Inflammatory Bowel Disease: A Single-Medical-Center Retrospective Analysis in Taiwan. JCM 2022;11:5050. [DOI: 10.3390/jcm11175050] [Reference Citation Analysis]
2 Hyun HK, Zhang H, Yu J, Kang EA, Park J, Park SJ, Park JJ, Kim TI, Kim WH, Cheon JH. Comparative effectiveness of second-line biological therapies for ulcerative colitis and Crohn’s disease in patients with prior failure of anti-tumour necrosis factor treatment. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02225-w] [Reference Citation Analysis]
3 Oh K, Oh EH, Noh SM, Park SH, Kim N, Hwang SW, Park SH, Yang D, Byeon J, Myung S, Yang S, Ye BD. Combined Endoscopic and Radiologic Healing Is Associated With a Better Prognosis Than Endoscopic Healing Only in Patients With Crohn's Disease Receiving Anti-TNF Therapy. Clin Transl Gastroenterol 2022;Publish Ahead of Print. [DOI: 10.14309/ctg.0000000000000442] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Na SY, Lim YJ. Capsule Endoscopy in Inflammatory Bowel Disease: When? To Whom? Diagnostics (Basel) 2021;11:2240. [PMID: 34943477 DOI: 10.3390/diagnostics11122240] [Reference Citation Analysis]
5 Yoon H. Another Piece of Evidence for Early Administration of Biologics in Children with Crohn's Disease Who Start as an Inflammatory Phenotype. Gut Liver 2021;15:791-2. [PMID: 34782486 DOI: 10.5009/gnl210508] [Reference Citation Analysis]
6 Rakowsky S, Cheifetz AS, Papamichael K. Editorial: higher concentrations of cytokine blockers are needed to obtain small bowel mucosal healing during maintenance therapy in Crohn's disease. Aliment Pharmacol Ther 2021;54:1085-6. [PMID: 34564884 DOI: 10.1111/apt.16571] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lee C, Hong SN, Kim ER, Chang DK, Kim YH. Epithelial Regeneration Ability of Crohn's Disease Assessed Using Patient-Derived Intestinal Organoids. Int J Mol Sci 2021;22:6013. [PMID: 34199463 DOI: 10.3390/ijms22116013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Yoon J, Kim DS, Kim YJ, Lee JW, Hong SW, Hwang HW, Hwang SW, Park SH, Yang DH, Ye BD, Byeon JS, Myung SJ, Yang SK. Risk factors and prognostic value of acute severe lower gastrointestinal bleeding in Crohn’s disease . World J Gastroenterol 2021; 27(19): 2353-2365 [PMID: 34040327 DOI: 10.3748/wjg.v27.i19.2353] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Lee YJ. Is Paradigm for the Role of Balloon-Assisted Enteroscopy Changing in Crohn's Disease? Gut Liver 2021;15:325-6. [PMID: 33988130 DOI: 10.5009/gnl210194] [Reference Citation Analysis]